| Medivation, Inc. |
A class action lawsuit has been filed on behalf of purchasrs of Medivation, Inc. common stock during the period from July 17, 2008 throuh March 2, 2010. The lawsuit alleges that the Company failed to disclose material adverse news about its developmental drug Dimebon. As a result, the complaint alleges the price of Medivation stock was inflated during the class period. When the truth was disclosed on March 3, 2010, Medivation's stok price dropped more than $27.00 per share. To join the Medivation, Inc. securities class action click on the link to the right of this page=> |
| For more Information | |
 Case Summary
|
|
|
Press Release
|
|
 Read the Complaint
|
|
|